Cannabis use and vulnerability for psychosis in early adolescence-a TRAILS study

Addiction

Volumn 108, Issue 4, 2013, Pages 733-740

  Griffith Lendering, Merel F H ^a   Wigman, Johanna T W ^b,c   van Leeuwen, Andrea Prince ^d   Huijbregts, Stephan C J ^a   Huizink, Anja C ^d   Ormel, Johan ^e   Verhulst, Frank C ^f   Van Os, Jim ^c,g   Swaab, Hanna ^a   Vollebergh, Wilma A M ^b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Addictions; Adolescence; Bidirectional association; Cannabis; Drugs of abuse; Vulnerability for psychosis

Indexed keywords

ADOLESCENT; ARTICLE; ATTENTION; CANNABIS ADDICTION; DRUG EFFECT; FEMALE; HEALTH; HUMAN; HUMAN RELATION; MALE; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOSIS; SELF REPORT; SOCIOECONOMICS; YOUNG ADULT; DRUG EFFECTS; PSYCHOLOGY; PSYCHOTIC DISORDERS;

ADOLESCENT; ATTENTION; FEMALE; HUMANS; INTERPERSONAL RELATIONS; MALE; MARIJUANA ABUSE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RURAL HEALTH; SELF REPORT; SOCIOECONOMIC FACTORS; URBAN HEALTH; YOUNG ADULT;

EID: 84891456217     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12050     Document Type: Article

References (52)

1. Arsenault L., Cannon M., Poulton R., Murray R., Caspi A., Moffitt T. E. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002; 325: 1212-3.
2. Compton M. T., Kelley M. E., Ramsay C. E., Pringle M., Goulding S. M., Esterberg M. L. et al. Association of preonset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients. Am J Psychiatry 2009; 166: 1251-7.
3. Fergusson D. M., Horwood L. J., Swain-Campbell N. R. Cannabis dependence and psychotic symptoms in young people. Psychol Med 2003; 33: 15-21.
4. Henquet C., Krabbendam L., Spauwen J., Kaplan C., Lieb R., Lieb H. U. et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005; 330: 11.
5. Kuepper R., van Os J., Lieb R., Wittchen H., Höfler M., Henquet C. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ 2011; 342: d738.
6. Manrique-Garcia E., Zammit S., Hemmingsson T., Andreasson S., Allebeck P. Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort. Psychol Med 2012; 42: 1321-8.
7. Moore T. H. M., Zammit S., Lingford-Hughes A., Barnes T. R. E., Jones P. B., Burke M. et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319-28.
8. Rössler W., Hengartner M. P., Angst J., Ajdacic-Gross V. Linking substance use with symptoms of subclinical psychosis in a community cohort over 30 years. Addiction 2012; 107: 1174-84.
9. Van Gastel W. A., Wigman J. T. W., Monshouwer K., Kahn R. S., van Os J., Boks M. P. M. et al. Cannabis use and subclinical positive psychotic experiences in early adolescence: findings from a Dutch survey. Addiction 2011; 107: 381-7.
10. Khantzian E. J. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry 1997; 4: 231-44.
11. Kolliakou A., Joseph C., Ismail K., Atakan Z., Murray R. M. Why do patients with psychosis use cannabis and are they ready to change their use? Int J Dev Neurosci 2011; 29: 335- 46.
12. Ferdinand R. F., Sondeijker F., van der Ende J., Selten J., Huizink A., Verhulst F. C. Cannabis use predicts future psychotic symptoms, and vice versa. Addiction 2005; 100: 612-8.
13. Bhattacharyya S., Morrison P. D., Fusar-Poli P., Martin-Santos R., Borgwardt S., Winton-Brown T. et al. Opposite effects of D-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology 2010; 35: 764-74.
14. Morrison P. D., Murray R.M. From real-world events to psychosis: the emerging neuropharmacology of delusions. Schizophr Bull 2009; 35: 668-74.
15. Bossong M. G., Niesink R. J. M. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Prog Neurobiol 2010; 92: 370-85.
16. Schneider M. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addict Biol 2008; 13: 253-63.
17. Gill M., Donohoe G., Corvin A. What have genomics ever done for the psychoses? Psychol Med 2010; 40: 529-40.
18. Rijsdijk F. V., Gottesman I. I., McGuffin P., Cardno A. G. Heritability estimates for psychotic symptom dimensions in twins with psychotic disorders. Am J Med Genet B Neuropsychiatr Genet 2011; 156B: 89-98.
19. Bearden C. E., Rosso I. M., Hollister J. M., Sanchez L. E., Hadley T., Cannon T. D. A prospective cohort study of childhood behavioral deviance and language abnormalities as predictors of adult schizophrenia. Schizophr Bull 2000; 26: 395-410.
20. Tarbox S. I., Pogue-Geile M. F. Development of social functioning in preschizophrenia children and adolescents: a systematic review. Psychol Bull 2008; 134: 561-83.
21. Welham J., Scott J., Williams G. M., Najman J., Bor W., O'Callaghan M. et al. Emotional and behavioural antecedents of young adults who screen positive for non-affective psychosis: a 21-year birth cohort study. Psychol Med 2009; 39: 625-34.
22. Wigman J. T.W., VolleberghW. A. M., Raaijmakers Q. A.W., Iedema J., van Dorsselaer S., Ormel J. et al. The structure of the extended psychosis phenotype in early adolescence-a cross-sample replication. Schizophr Bull 2009; 37: 850-60.
23. Poulton R., Caspi A., Moffit T. E., Cannon M., Murray R., Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch Gen Psychiatry 2000; 57: 1053-8.
24. Wigman J. T. W., Van Winkel R., Raaijmakers Q. A. W., Ormel J., Verhulst F. C., Reijneveld S. Evidence for a persistent, deteriorating subtype of subclinical psychotic experiences: a six-year longitudinal general population study. Psychol Med 2011; 41: 2317-29.
25. Yung A. R., Nelson B., Baker K., Buckby J. A., Baksheev G. N., Cosgrave E. M. Psychotic-like experiences in a community sample of adolescents: implications for the continuum model of psychosis and prediction of schizophrenia. Aust NZ J Psychiatry 2009; 43: 118-28.
26. Fergusson D. M., Boden J. M., Horwood L. J. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction 2006; 101: 556-69.
27. Large M., Sharma S., Compton M. T., Slade T., Nielssen O. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry 2011; 68: 555-61.
28. Schubart C. D., Van Gastel V. A., Breetvelt E. J., Beetz S. L., Ophoff R. A., Sommer I. E. C. et al. Cannabis use at a young age is associated with psychotic experiences. Psychol Med 2010; 41: 1-10.
29. Stefanis C. N., Van Os J. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 2004; 99: 1333-41.
30. Huisman M., Oldehinkel A. J., deWinter A., Minderaa R. B., de Bildt A., Huizink A. C. et al. Cohort profile: the Dutch 'TRacking Adolescents' Individual Lives' Survey'; TRAILS. Int J Epidemiol 2008; 37: 1227-35.
31. De Winter A., Oldehinkel A. J., Veenstra R., Brunnekreef J. A., Verhulst F. C., Ormel J. Evaluation of non-response bias in mental health determinants and outcomes in a large sample of pre-adolescents. Eur J Epidemiol 2005; 20: 173-81.
32. Griffith-Lendering M. F. H., Huijbregts S. C. J., Mooijaart A., Vollebergh W. A. M., Swaab H. Cannabis use and development of externalizing and internalizing behaviour problems in early adolescence; a TRAILS study. Drug Alcohol Depend 2011; 116: 11-7.
33. Monshouwer K., Van Dorsselaer S., Verdurmen J., Ter Bogt T., De Graaf R., Vollebergh W. Cannabis use and mental health in secondary school children. Findings from a Dutch survey. Br J Psychiatry 2006; 188: 148-53.
34. Tukey J. W. Exploratory Data Analysis. Reading, MA: Addison-Wesley; 1977.
35. Achenbach T. M., Rescorla L. A. Manual for the Aseba Schoolage Forms and Profiles. Burlington, VT: University of Vermont, Research Center for Children Youth and Families; 2001.
36. Verhulst F. C., Achenbach T. M. Empirically-based assessment and taxonomy of psychopathology: cross-cultural applications.Areview. Eur Child Adolesc Psychiatry 1995; 4: 61-76.
37. Ormel J., Oldehinkel A. J., Ferdinand R. F., Hartman C. A., De Winter A. F., Veenstra R. et al. Internalizing and externalizing problems in adolescence: general and dimensionspecific effects of familial loadings and preadolescent temperament traits. Psychol Med 2005; 35: 1825-35.
38. Veenstra R., Lindenberg S., Oldehinkel A. J., DeWinter A. F., Verhulst F. C., Ormel J. Bullying and victimization in elementary schools: a comparison of bullies, victims, bully/victims, and uninvolved preadolescents. Dev Psychol 2005; 41: 672-82.
39. Schafer J. L. Analysis of Incomplete Multivariate Data. London: Chapman and Hall; 1997.
40. Schafer J. L., Graham J. W. Missing data: our view of the state of the art. Psychol Methods 2002; 7: 147-77.
41. Anderson J. C., Gerbing D.W. Structural equation modelling in practice: a review and recommended two-step approach. Psychol Bull 1988; 103: 411-23.
42. Steiger J. H. A note on multiple sample extensions of the RMSEA fit index. Structural Equation Modeling 1988; 5: 411-9.
43. Browne M. W., Cudeck R. Alternative ways of assessing model fit. In: Bollen K. A., Long J. S., editors. Testing Structural Equation Models. Newbury Park, CA: Sage; 1993, p. 136-62.
44. Bentler P. M. Comparative fit indexes in structural models. Psychol Bull 1990; 107: 238-46.
45. Bentler P. M. EQS Structural Equations Program Manual. Encino, CA: Multivariate Software; 1995.
46. Schofield D., Tennant C., Mash L., Degenhardt L., Cornish A., Hobbs C. et al. Reasons for cannabis use in psychosis. Aust NZ J Psychiatry 2006; 40: 570-4.
47. Caspi A., Moffit T. E., Cannon M., McClay J., Murray R., Harrington H. et al. Moderation of the effect of adolescentonset cannabis use on adult psychosis by a functional polymorphism in the Catechol-O-Methyltransferase gene: longitudinal evidence of a gene environment interaction. Biol Psychiatry 2005; 57: 1117-27.
48. Cougnard A., Mercelis M., Myin-Germeys I., de Graaf R., Vollebergh W., Krabbendam L. et al. Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness-persistence model. Psychol Med 2007; 37: 513-27.
49. Decoster J., Van Os J., Myin-Germeys I., De Hert M., Van Winkel R. (2012). Genetic variation underlying psychosisinducing effects of cannabis: critical review and future directions. Curr Pharm Des, 18, 5015-23.
50. Henquet C., Di Forti M., Morrison P., Kuepper R., Murray R. M. Gene-Environment interplay between cannabis and psychosis. Schizophr Bull 2008; 34: 1111-21.
51. BuchanB. J., DennisM.L., Tims F. M.,DiamondG. J.Cannabis use: consistency and validity of self-report, on-site urine testing and laboratory testing. Addiction 2002; 97: 98-108.
52. R̈ssler W., Hengartner M. P., Ajdacic-Gross V., Haker H., Gamma A., Angst J. Sub-clinical psychosis symptoms in young adults are risk factors for subsequent mental disorders. Schizophr Res 2011; 13: 18-23.